Der Einfluss von Arzneimitteln auf die Mundschleimhaut
Tóm tắt
Từ khóa
Tài liệu tham khảo
Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259
Nebeker JR, Barach P, Samore MH (2004) Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med 140:795–801
Gomes ER, Demoly P (2005) Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 5:309–316
Vogt T (2010) Unerwünschte Arzneimittelwirkungen im Orofazialbereich.In. In: Balogh A, Haen E (Hrsg) Klinische Pharmakologie in der zahnärztlichen Praxis. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 191–203
Halling F (2013) Zahnärztlich relevante Neben- und Wechselwirkungen der meistverordneten Arzneimittel in Deutschland. Dtsch Zahnärztl Z 68:669–676
Smith RG, Burtner AP (1994) Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist 14:96–102
Wilmes E, Landthaler M (1986) Nebenwirkungen von Medikamenten auf Speicheldrüsen und Mundschleimhaut. Laryngorhinootologie 65:470–476
De Almeida Pdel V, Grégio AM, Machado MA et al (2008) Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 9:72–80
Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E et al (2015) Salivary secretory disorders, inducing drugs, and clinical management. Int J Med Sci 12:811–824
Zavras AI, Rosenberg GE, Danielson JD et al (2013) Adverse drug and device reactions in the oral cavity: surveillance and reporting. J Am Dent Assoc 144:1014–1021
Nederfors T, Isaksson R, Mörnstad H et al (1997) Prevalence of perceived symptoms of dry mouth in an adult Swedish population—relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 25:211–216
Mintzer J, Burns A (2000) Anticholinergic side-effects of drugs in elderly people. J R Soc Med 93:457–462
Herrmann G, Müller K, Behr M et al (2017) Xerostomie und ihr Einfluss auf die mundgesundheitsbezogene Lebensqualität. Z Gerontol Geriatr 50:145–150
Singh ML, Papas A (2014) Oral implications of polypharmacy in the elderly. Dent Clin North Am 58:783–796
Yuan A, Woo SB (2015) Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol 119:35–47
Santander Martinez PM, Moser N (2014) Medikamentös bedingte Schleimhautveränderungen. Quintessenz 65:1507–1518
Durán CE, Azermai M, Vander Stichele RH (2013) Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol 69:1485–1496
Kiesel EK, Hopf YM, Drey M (2018) An anticholinergic burden score for German prescribers: score development. BMC Geriatr 18:239
Tan ECK, Lexomboon D, Sandborgh-Englund G et al (2018) Medications that cause dry mouth as an adverse effect in older people: a systematic review and metaanalysis. J Am Geriatr Soc 66:76–84
Peeters FP, deVries MW, Vissink A (1998) Risks for oral health with the use of antidepressants. Gen Hosp Psychiatry 20:150–154
McGrath C, Chan B (2005) Oral health sensations associated with illicit drug abuse. Br Dent J 198:159–162 (dicussion 147; quiz 174)
Tschoppe P, Wolgin M, Pischon N et al (2010) Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int 41:321–333
Ackerman BH, Kasbekar N (1997) Disturbances of taste and smell induced by drugs. Pharmacotherapy 17:482–496
Marinone MG, Savoldi E (2000) Chlorhexidine and taste. Influence of mouthwashes concentration and of rinsing time. Minerva Stomatol 49:221–226
Tuccori M, Lapi F, Testi A et al (2011) Drug-induced taste and smell alterations: a case/non-case evaluation of an italian database of spontaneous adverse drug reaction reporting. Drug Saf 34:849–859
Paulmann M, Mockenhaupt M (2015) Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy. J Dtsch Dermatol Ges 13:625–645
Lerch M, Mainetti C, Terziroli Beretta-Piccoli B et al (2018) Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clin Rev Allergy Immunol 54:147–176
Mockenhaupt M (2009) Severe cutaneous adverse drug reactions. In: Burgdorf WHC, Plewig G, Wolff HH, Landthaler M (Hrsg) Braun-Falco’s Dermatology. Springer, BerlinHeidelberg, S 473–484
Holmes RG, Chan DC, Singh BB (2004) Chemical burns of the buccal mucosa. Am J Dent 17:219–220
Stamer UM, Gundert-Remy U, Biermann E et al (2017) Metamizol: Überlegungen zum Monitoring zur frühzeitigen Diagnose einer Agranulozytose. Schmerz 31:5–13
Böger R (2022) Symptomatische Behandlung von Schmerz, Fieber und Entzündung. In: Ludwig W‑D, Mühlbauer B, Seifert R (Hrsg) Arzneiverordnungs-Report 2022. Springer, Berlin Heidelberg, S 387–412
Hoffmann F, Bantel C, Jobski K (2020) Agranulocytosis attributed to metamizole: an analysis of spontaneous reports in Eudra vigilance 1985–2017. Basic Clin Pharmacol Toxicol 126:116–126
Özkaya E (2013) Oral mucosal fixed drug eruption: characteristics and differential diagnosis. J Am Acad Dermatol 69:e51–e58
Esteves CV, de Campos WG, Paredes WEB et al (2020) Could sodium lauryl sulfate be an irritant factor in oral mucosal desquamation? Int J Case Rep Images 11:101184Z01CE2020
Forouzan P, Riahi RR, Cohen PR (2020) Atorvastatin-induced lichenoid drug eruption: a case report and review of statin-associated cutaneous adverse events. Cureus 12:e7155
Lamey PJ, Gibson J, Barclay SC et al (1990) Grinspan’s syndrome: a drug-induced phenomenon? Oral Surg Oral Med Oral Pathol 70:184–185
Kamath VV, Setlur K, Yerlagudda K (2015) Oral lichenoid lesions—a review and update. Indian J Dermatol 60:102
Soto AP, Meyer SL (2021) Oral implications of polypharmacy in older adults. Dent Clin North Am 65:323–343
Meleti M, Vescovi P, Mooi WJ et al (2008) Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:606–616
Sreeja C, Ramakrishnan K, Vijayalakshmi D et al (2015) Oral pigmentation: a review. J Pharm Bioallied Sci 7(Suppl 2):S403–S408
Scully C, Bagan JV (2004) Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 15:221–239
Schriber M, Feldmeyer L, Suter VGA (2020) Melanotische Flecken in der Mundhöhle. Quintessenz 71:66–76
Mallagray-Montero MC, Moreno-López LA, Cerero-Lapiedra R (2022) Medication related to pigmentation of oral mucosa. Med Oral Patol Oral Cir Bucal 27:e230–e237
Ellis JS, Seymour RA, Steele JG et al (1999) Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol 70:63–67
Fattore L, Stablein M, Bredfeldt G et al (1991) Gingival hyperplasia: a side effect of nifedipine and diltiazem. Spec Care Dentist 11:107–109
Gallo C, Bonvento G, Zagotto G et al (2021) Gingival overgrowth induced by anticonvulsant drugs: A cross-sectional study on epileptic patients. J Periodontal Res 56:363–369
Droździk A, Droździk M (2023) Drug-induced gingival overgrowth-molecular aspects of drug actions. Int J Mol Sci 24:5448
Seymour RA (2006) Effects of medications on the periodontal tissues in health and disease. Periodontol 2000 40:120–129
Hatahira H, Abe J, Hane Y et al (2017) Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases. J Pharm Health Care Sci 3:19
Schwarz I, Bokanovic D, Aberer W (2016) Schleimhauterkrankungen aus allergologischer Sicht. Hautarzt 67:780–785
Halling F (2017) Das nicht-allergische, arzneimittelinduzierte Angioödem. Hess Ärztebl 78:482–484
Jackeviciute J, Pilvinis V, Pilviniene R (2018) Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema: A case report. Medicine 97:e11695
Ulmer JL, Garvey MJ (1992) Fatal angioedema associated with lisinopril. Ann Pharmacother 26(10):1245–1246
Bork K (2010) Recurrent angioedema and the threat of asphyxiation. Dtsch Ärztebl Int 107:408–414
Mair M, Baur D, Endermann S et al (2013) ACE-Hemmer und Angioödem: eine Zeitbombe? Schweiz Med Forum 13:164–166
Wissenschaftliches Institut der Ortskrankenkassen (WIdO) (2020) GKV-Arzneimittelindex. Wissenschaftliches Institut der AOK, Berlin
Bernstein JA, Cremonesi P, Hoffmann TK et al (2017) Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med 10:15
Scott FI, Mamtani R, Brensinger CM et al (2015) Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer. JAMA Dermatol 152:164–172